CN103301266A - 一种治疗前列腺肥大的中药 - Google Patents
一种治疗前列腺肥大的中药 Download PDFInfo
- Publication number
- CN103301266A CN103301266A CN201310171343XA CN201310171343A CN103301266A CN 103301266 A CN103301266 A CN 103301266A CN 201310171343X A CN201310171343X A CN 201310171343XA CN 201310171343 A CN201310171343 A CN 201310171343A CN 103301266 A CN103301266 A CN 103301266A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- treating
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract description 5
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title abstract description 5
- 210000002307 prostate Anatomy 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 8
- 240000000759 Lepidium meyenii Species 0.000 claims description 8
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 206010020718 hyperplasia Diseases 0.000 claims description 7
- 241000545442 Radix Species 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 239000002775 capsule Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 238000003756 stirring Methods 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 208000031971 Yin Deficiency Diseases 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 10
- 206010020880 Hypertrophy Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000006750 hematuria Diseases 0.000 description 5
- 239000009636 Huang Qi Substances 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000003708 urethra Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010046555 Urinary retention Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- ZZIZZTHXZRDOFM-UHFFFAOYSA-N 2-(2-ethoxyphenoxy)ethyl-[1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl]azanium;chloride Chemical compound Cl.CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003198 tamsulosin hydrochloride Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 例数 | 显效(n%) | 好转(n%) | 无效(n%) | 总有效率(n%) |
治疗组 | 70 | 45(64.3%) | 20(28.6%) | 5(7.1%) | 92.9% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310171343.XA CN103301266B (zh) | 2013-05-11 | 2013-05-11 | 一种治疗前列腺肥大的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310171343.XA CN103301266B (zh) | 2013-05-11 | 2013-05-11 | 一种治疗前列腺肥大的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103301266A true CN103301266A (zh) | 2013-09-18 |
CN103301266B CN103301266B (zh) | 2015-04-15 |
Family
ID=49127272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310171343.XA Expired - Fee Related CN103301266B (zh) | 2013-05-11 | 2013-05-11 | 一种治疗前列腺肥大的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103301266B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412837A (zh) * | 2015-12-21 | 2016-03-23 | 孙红霞 | 一种治疗前列腺肥大的药物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090280203A1 (en) * | 2008-05-08 | 2009-11-12 | Gonzales Rengifo Gustavo Francisco | COMPOSITIONS OF ATOMIZED OR LYOPHILIZED MACA (Lepidium meyenii) EXTRACTS AND ATOMIZED OR LYOPHILIZED YACON (Smallanthus sanchifolius) EXTRACTS AS ADJUVANTS IN THE TREATMENT OF DIFFERENT CONDITIONS |
CN101843787A (zh) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
CN102240320A (zh) * | 2011-07-04 | 2011-11-16 | 河南中医学院 | 一种治疗前列腺增生的益芪胶囊 |
CN102526428A (zh) * | 2012-02-21 | 2012-07-04 | 简福川 | 一种治疗前列腺增生的中药 |
-
2013
- 2013-05-11 CN CN201310171343.XA patent/CN103301266B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090280203A1 (en) * | 2008-05-08 | 2009-11-12 | Gonzales Rengifo Gustavo Francisco | COMPOSITIONS OF ATOMIZED OR LYOPHILIZED MACA (Lepidium meyenii) EXTRACTS AND ATOMIZED OR LYOPHILIZED YACON (Smallanthus sanchifolius) EXTRACTS AS ADJUVANTS IN THE TREATMENT OF DIFFERENT CONDITIONS |
CN101843787A (zh) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
CN102240320A (zh) * | 2011-07-04 | 2011-11-16 | 河南中医学院 | 一种治疗前列腺增生的益芪胶囊 |
CN102526428A (zh) * | 2012-02-21 | 2012-07-04 | 简福川 | 一种治疗前列腺增生的中药 |
Non-Patent Citations (1)
Title |
---|
肖伟等: "秘鲁特产药用植物玛卡研究的新进展", 《世界科学技术-中医药现代化》, vol. 9, no. 3, 31 December 2007 (2007-12-31) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412837A (zh) * | 2015-12-21 | 2016-03-23 | 孙红霞 | 一种治疗前列腺肥大的药物 |
Also Published As
Publication number | Publication date |
---|---|
CN103301266B (zh) | 2015-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102151325A (zh) | 一种治疗乳腺疾病的中药 | |
CN103908628B (zh) | 一种治疗慢性盆腔炎的中药灌肠药剂及其制备方法 | |
CN103599472B (zh) | 一种用于治疗前列腺增生的中药组合物 | |
CN1895434B (zh) | 一种治疗子宫肌瘤的药物 | |
CN101195011A (zh) | 一种治疗前列腺炎、增生的中药 | |
CN103301266B (zh) | 一种治疗前列腺肥大的中药 | |
CN101700390B (zh) | 一种内服治疗脂肪肝的中药组合物 | |
CN103705876A (zh) | 一种治疗小儿遗尿症的中药汤剂 | |
CN103655845A (zh) | 一种治疗子宫脱垂的中药组合物 | |
CN102846744B (zh) | 一种治疗前列腺肥大的药物 | |
CN106236964A (zh) | 一种治疗骨关节疾病的中药 | |
CN105031505A (zh) | 一种治疗良性前列腺增生肥大的药物及其制备方法 | |
CN1292764C (zh) | 治疗妇女产后病的中药丸剂 | |
CN103656063A (zh) | 用于治疗慢性前列腺炎的药物 | |
CN103585575B (zh) | 一种用于胆结石及前列腺增生的中药组合物 | |
CN102274472A (zh) | 一种治疗女性痛经的中药贴剂及制备 | |
CN104721638A (zh) | 一种用于治疗前列腺炎的中药制剂 | |
CN101954043A (zh) | 一种治疗骨质增生的药物及其制备方法 | |
CN105412837A (zh) | 一种治疗前列腺肥大的药物 | |
CN105998421A (zh) | 治疗子宫肌瘤的中药组合物 | |
CN105688056A (zh) | 一种治疗泌尿系结石的药物及其制备方法 | |
CN104352950A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN104383417A (zh) | 一种治疗乳腺癌的药物 | |
CN103127352B (zh) | 一种治疗血瘀型月经不调的中药组合物 | |
CN103948719A (zh) | 复方毛冬青灌肠液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SECOND HOSPITAL OF SHANXI MEDICAL UNIVERSITY Free format text: FORMER OWNER: LIU YUEZE Effective date: 20150311 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Yueze Inventor after: Fang Zhenhuan Inventor after: Wang Xiangli Inventor after: Li Shaogang Inventor after: Zhang Di Inventor before: Liu Yueze |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU YUEZE TO: LIU YUEZE FANG ZHENHUAN WANG XIANGLI LI SHAOGANG ZHANG DI Free format text: CORRECT: ADDRESS; FROM: 042400 LINFEN, SHAANXI PROVINCE TO: 030000 TAIYUAN, SHAANXI PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150311 Address after: 030000 No. 382 Wuyi Road, Shanxi, Taiyuan, China Applicant after: The Second Hospital of Shanxi Medical University Address before: Shanxi city of Linfen Province, Beijing village 042400 ancient town of Peking Applicant before: Liu Yueze |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150415 Termination date: 20200511 |